Yangle Li

87 Xiangya Rd
Changsha, 410008, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Pelvic lymph node dissection in prostate cancer: current evidence, controversies, and future directions.

Pelvic lymph node dissection in prostate cancer: current evidence, controversies, and future directions.

Journal: Annals of medicine
Published: April 18, 2026

Deciphering the role of tubulin's C-terminal tail in kinesin binding using computational and clustering approaches.

Deciphering the role of tubulin's C-terminal tail in kinesin binding using computational and clustering approaches.

Journal: Scientific reports
Published: March 03, 2026

Enhancing the therapeutic efficacy of gemcitabine in bladder cancer through TGF-β1 inhibition and pluronic F-127-based microsphere delivery.

Enhancing the therapeutic efficacy of gemcitabine in bladder cancer through TGF-β1 inhibition and pluronic F-127-based microsphere delivery.

Journal: Journal of biological engineering
Published: February 27, 2025

ATXN3 promotes prostate cancer progression by stabilizing YAP.

ATXN3 promotes prostate cancer progression by stabilizing YAP.

Journal: Cell communication and signaling : CCS
Published: December 12, 2022

Clinical implications of 3D printing technology in preoperative evaluation of partial nephrectomy.

Clinical implications of 3D printing technology in preoperative evaluation of partial nephrectomy.

Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Published: May 11, 2022

Serum IL-6 level is associated with clinical outcome of intravesical gemcitabine therapy in T1 non-muscle-invasive bladder cancer.

Serum IL-6 level is associated with clinical outcome of intravesical gemcitabine therapy in T1 non-muscle-invasive bladder cancer.

Journal: Urologic oncology
Published: December 22, 2021

Niban apoptosis regulator 1 promotes gemcitabine resistance by activating the focal adhesion kinase signaling pathway in bladder cancer.

Niban apoptosis regulator 1 promotes gemcitabine resistance by activating the focal adhesion kinase signaling pathway in bladder cancer.

Journal: Journal of Cancer
Published: August 19, 2021

Competing endogenous RNA network analysis reveals pivotal ceRNAs in bladder urothelial carcinoma.

Competing endogenous RNA network analysis reveals pivotal ceRNAs in bladder urothelial carcinoma.

Journal: Translational andrology and urology
Published: March 15, 2021

Identification of key genes and microRNA regulatory network in development and progression of urothelial bladder carcinoma.

Identification of key genes and microRNA regulatory network in development and progression of urothelial bladder carcinoma.

Journal: Translational andrology and urology
Published: February 03, 2021

LncRNA SNHG9 is a prognostic biomarker and correlated with immune infiltrates in prostate cancer.

LncRNA SNHG9 is a prognostic biomarker and correlated with immune infiltrates in prostate cancer.

Journal: Translational andrology and urology
Published: February 03, 2021

Clinicopathologic Features and Survival Outcomes for Primary Renal Neuroendocrine Neoplasms.

Clinicopathologic Features and Survival Outcomes for Primary Renal Neuroendocrine Neoplasms.

Journal: Clinical genitourinary cancer
Published: July 20, 2020

Serum CXCL5 level is associated with tumor progression in penile cancer.

Serum CXCL5 level is associated with tumor progression in penile cancer.

Journal: Bioscience reports
Published: June 17, 2020
Showing 1-12 of 28

Last Updated: 09/26/2026